|
|
|
|
|
02.11.26 - 00:48
|
Mesoblast Board Changes (GlobeNewswire EN)
|
|
|
NEW YORK, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced rotational changes and retirement of certain members of its Board, and reiterated its intention to add new members with the requisite global commercial experience in the biopharmaceutical sector in line with its next phase of commercial delivery and growth....
|
|
|
|
|
|
|
|
|
28.10.26 - 02:36
|
Should I buy Cochlear and Mesoblast shares with $5,000? (Fool)
|
|
|
These two companies are at different stages of their growth journeys. Here's which I'd choose for a long-term investment.
The post Should I buy Cochlear and Mesoblast shares with $5,000? appeared first on The Motley Fool Australia....
|
|
|
23.10.26 - 23:00
|
Should I invest $2,000 into Mesoblast shares? (Fool)
|
|
|
I look at whether commercial progress has made this long-awaited biotech story worth investing in today.
The post Should I invest $2,000 into Mesoblast shares? appeared first on The Motley Fool Australia....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.09.26 - 13:01
|
Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product (GlobeNewswire EN)
|
|
|
NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received approval from the United States Food and Drug Administration (FDA) to implement a new potency assay, T-cell Proliferation Inhibition BioAssay (TIBA), for release and stability monitoring of all new commercial product lots of its FDA-approved mesenchymal stromal cell (MSC) product Ryoncil® (remestemcel-L-rknd)....
|
|
|
|
|
24.09.26 - 02:48
|
Mesoblast wins FDA nod for new Ryoncil potency test (Fool)
|
|
|
Mesoblast gets FDA approval for a new Ryoncil potency assay, aiming to ensure quality and support product expansion.
The post Mesoblast wins FDA nod for new Ryoncil potency test appeared first on The Motley Fool Australia....
|
|
|
01.09.26 - 06:36
|
Buy, hold, sell: Challenger, APA Group, Mesoblast shares (Fool)
|
|
|
Experts reveal their insights on these stocks in the finance, utilities, and healthcare sectors.
The post Buy, hold, sell: Challenger, APA Group, Mesoblast shares appeared first on The Motley Fool Australia....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
